Notwithstanding various setbacks, several MDM2 inhibitors have now progressed into late-phase scientific development. New approaches have also been designed to reinforce the efficacy of MDM2 inhibitors and also to mitigate their on-focus on toxicity. With this evaluation, we summarize the progress and troubles in the event of a MDM2 qualified thera